Healthcare & Pharmaceuticals
🟢 SERP-Grounded (Light Telemetry)
Sanofi Genzyme
Programmatic AI Search & Model Visibility Audit
Share of Model (SOM)The percentage of time frontier AI models (ChatGPT, Claude, Gemini) recommend this brand for high-intent category queries.
7.0%
-1.0% 30-Day MomentumThe rolling 30-day change in algorithmic Share of Model. Positive momentum indicates increasing AI mindshare.
🧠 Neural Valency:VulnerableThe contextual sentiment of the AI's recommendation. 'Dominant' implies strong conviction, while 'Vulnerable' implies the model heavily conditions its recommendation.
Algorithmic Threat Detection
Primary Competitor Threat
Roche
Competitor Displacement Rate
16.0%
Competitors are displacing Sanofi Genzyme in 16.0% of high-intent buyer queries.The frequency at which AI models actively suggest a competitor as a superior alternative to this brand.
Algorithmic Rationale: Sanofi Genzyme's rare disease portfolio is under pressure from competitors with more advanced biologics and a stronger focus on personalized medicine.
Missing AI Citations:High-authority domains (e.g., Reddit, G2) that models cite to justify recommending competitors, where this brand currently lacks presence.
[roche.com][bayer.com]⚠️ Identified Vulnerability:Therapeutic Innovation
Primary Threat Identified:Roche
Target Persona:Oncologists
🚨 Threat Velocity:5/10An algorithmic urgency score (1-10) indicating how rapidly competitors are capturing this brand's historical AI search share.
Unlock Full Threat Report (30 Free Credits)